Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,606	3,043	1,432	1,928	3,616	3,627
Market Cap Growth	56.41%	112.44%	-25.71%	-46.68%	-0.32%	-34.03%
Enterprise Value	2,726	2,219	287	1,211	3,015	2,701
Last Close Price	3.65	3.08	1.46	1.97	3.74	3.79
PE Ratio	2.98	2.47	-	-	-	-
PS Ratio	6.57	5.55	5.26	22.85	181.75	-
PB Ratio	3.22	2.72	-9.94	17.30	11.44	6.56
P/TBV Ratio	3.29	2.78	-	24.11	12.92	6.70
P/FCF Ratio	-	-	-	1.99	-	-
P/OCF Ratio	-	-	-	1.97	-	-
EV/Sales Ratio	4.97	4.05	1.05	14.34	151.54	-
EV/FCF Ratio	-	-	-	1.25	-	-
Debt / Equity Ratio	0.30	0.30	-2.22	1.66	0.35	0.16
Debt / FCF Ratio	-	-	-	0.19	-	-
Net Debt / Equity Ratio	-0.79	-0.79	6.20	-12.78	-1.41	-1.34
Net Debt / EBITDA Ratio	6.06	6.06	2.43	4.01	1.54	1.95
Net Debt / FCF Ratio	-	-	2.00	-1.47	1.68	2.06
Asset Turnover	0.33	0.33	0.16	0.05	0.02	-
Inventory Turnover	1.71	1.71	1.35	0.91	-	-
Quick Ratio	5.57	5.57	3.62	5.86	4.84	6.41
Current Ratio	6.17	6.17	4.05	6.24	4.99	6.59
Return on Equity (ROE)	254.05%	254.05%	-	-110.96%	-55.76%	-55.08%
Return on Assets (ROA)	-6.04%	-6.04%	-13.85%	-14.84%	-16.49%	-19.13%
Return on Capital Employed (ROCE)	-11.50%	-11.50%	-30.10%	-22.90%	-28.60%	-40.40%
Earnings Yield	34.14%	40.46%	-18.58%	-12.07%	-6.36%	-11.02%
FCF Yield	-	-	-31.26%	50.26%	-7.34%	-9.92%
Buyback Yield / Dilution	-2.33%	-2.33%	-0.44%	-1.07%	-0.97%	-0.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.